David J. Brailer, MD
David J. Brailer, M.D., Ph.D. has served as a member of the Walgreen Co. board of directors since 2010. He has been chairman of Health Evolution Partners since 2006.
In 2004, prior to joining Health Evolution Partners, he was appointed by the Bush Administration as the first National Health Information Technology Coordinator. In that role, Brailer was the architect of a bipartisan national effort to bring the health care system into the information age, toward transparency, quality and efficiency.
Before his presidential appointment, Brailer was a senior fellow at the Health Technology Center in San Francisco, a non-profit research and education organization that provides health care organizations with strategic information and resources about the future impact of technology in health care delivery.
In 1992, Brailer founded CareScience, Inc., a spin-off from The Wharton School of Business at the University of Pennsylvania, and an early leader in the use of the Internet to share health information and improve the quality of care across the United States.
Prior to 1992, Brailer was with the University of Pennsylvania School of Medicine and The Wharton School of Business. He founded the health information technology program at The Wharton School Health Care Management Department, taught health management and economics in The Wharton MBA program and lectured in The Wharton Executive Education program. He also was an active patient-care physician in general medicine and in immune deficiency at the University of Pennsylvania.
Brailer received a bachelor’s degree in political science and his M.D. from West Virginia University. He completed his residency in internal medicine at the University Of Pennsylvania School Of Medicine and earned a Ph.D. in health economics from The Wharton School of Business, where he taught health management for a decade.
Brailer serves on the board of directors for Optimal IMX, CenseoHealth, American Optical Services, and is a member of the Health Care Policy Advisory Council at Harvard Medical School.